The use of botulinum toxin A as an adjunctive therapy in the management of chronic musculoskeletal pain - Bia education

Scientific Literature Synthesis / Publication Summary / Battista et al. / 2021 / The use of botulinum toxin A as an adjunctive therapy in the management of chronic musculoskeletal pain

References

Battista, S., Buzzatti, L., Gandolfi, M., Finocchi, C., Falsiroli Maistrello, L., Viceconti, A., Giardulli, B., & Testa, M. (2021). The Use of Botulinum Toxin A as an Adjunctive Therapy in the Management of Chronic Musculoskeletal Pain: A Systematic Review with Meta-Analysis. Toxins, 13(9), 640.

This article is open access. Click here!

Discover this course:

Musculoskeletal webinar series

Click here!

More related content

Related content

Show more

Clinical Practice Guideline Summary

Hand Pain and Sensory Deficits Carpal Tunnel Syndrome Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability and Health From APTA Orthopedics and APTA Hand and Upper Extremity Academies of the American Physical Association

Author:

Erickson et al. 2026

Clinical Practice Guideline Summary

French Societies of Rheumatology and of Physical and Rehabilitation Medicine recommendations for the management of people living with hand osteoarthritis

Author:

Courties et al. 2026

Clinical Practice Guideline Summary

Clinical Practice Guideline: Nonspecific Neck Pain

Author:

El-Allawy et al. 2026

Clinical Practice Guideline Summary

Updated recommendations on knee osteoarthritis management: The Hong Kong College of Orthopaedic Surgeons position statement

Author:

Yau et al. 2026